Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria

Cytometry

Volumn 27, Issue 1, 1997, Pages 84-91

  Pattanapanyasat, Kovit ^a   Thaithong, Sodsri ^b   Kyle, Dennis E ^e   Udomsangpetch, Rachanee ^c   Yongvanitchit, Kosol ^d   Hider, Robert C ^f   Webster, H Kyle ^g  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Medical Department   (Singapore)

Author keywords

DNA; drug susceptibility testing; iron chelators; Plasmodium falciparum; propidium iodide

Indexed keywords

1,2 DIETHYL 3 HYDROXY 4 PYRIDINONE; 3 HYDROXY 1 METHOXYETHYL 2 METHYL 4 PYRIDINONE; 3 HYDROXY 1,2 DIMETHYL 3 PYRIDINONE; CHELATING AGENT; DEFEROXAMINE; IRON; PROPIDIUM IODIDE; PYRIDINE DERIVATIVE; PYRIMETHAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; COLORING AGENTS; DEFEROXAMINE; DNA, PROTOZOAN; DRUG RESISTANCE; ERYTHROCYTES; FLOW CYTOMETRY; IRON; IRON CHELATING AGENTS; MICROBIAL SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROPIDIUM; PYRIDONES;

EID: 0031027764     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970101)27:1<84::AID-CYTO11>3.0.CO;2-O     Document Type: Article

References (36)

1. Balcerzak SP, Westerman MP, Heinle EW, Taylor FH: Measurement of iron stores using desferoxamine. Ann Intern Med 68:518-525, 1968.
2. Chongsuphajaisiddhi T, Sabcharoen A, Phanorsri A: In vivo and in vitro sensitivity of Falciparum malaria to quinine in Thai children. Ann Trop Paediatr 1:21-26, 1981.
3. Dobbin PS, Hider RC, Hall AD, Taylor PD, Sarpong P, Porter JB, Ziao G, van der Helm D: Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4-(1H)-pyridinones: Orally active iron chelators with clinical potential. J Med Chem 36:2448-2458, 1993.
4. Franklin RM, Brun R, Grieder A: Microscopic and flow cytophotometric analysis of parasitemia in cultures of Plasmodium falciparum vitally stained with Hoechst 33342 - Application to studies of anti malarial agents. Z Parasitenkd 72:201-212, 1986.
5. Heppener DG, Hallaway PE, Kontoghiorghes GJ, Eaton JW: Antimalarial properties of orally active iron chelators. Blood 72:358-361, 1988.
6. Hershko C, Peto TEA: Deferoxamine inhibition of malaria is independent of host iron status. J Exp Med 168:375-387, 1988.
7. Hershko C, Theanacho EN, Spira DT, Peter HH, Dobbin P, Hider RC: The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. Blood 77:637-643, 1991.
8. Horward RJ, Battye FL: Plasmodium berghei-infected red cells sorted according to DNA content. Parasitology 78:263-270, 1979.
9. Hurwitz SD, Johnson D, Campbell CC: Resistance of Plasmodium falciparum to sulphodoxine pyrimethamine ("Fansidar") in a refugee camp in Thailand. Lancet I:1068-1070, 1981.
10. Janse CJ, van Vianen PH, Tanke HJ, Mons B, Ponnudurai T, Overdulve JP: Plasmodium species: Flow cytometry and microfluorometry assessment of DNA content and synthesis. Exp Parasitol 64:88-94, 1987.
11. Keberle H: The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci 119:758-768, 1964.
12. Lederman HM, Cohen A, Lee JWW, Freidman MH, Gelfand EW: Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation. Blood 64:748-753, 1984.
13. Makler MT, Lee LG, Recktenwald D: Thiazole orange: A new dye for Plasmodium species analysis. Cytometry 8:568-570, 1987.
14. Modell B, Berdoukas V: The Clinical Approach to Thalassaemia. Grune & Stratton, London, 1984.
15. Murray MJ, Murray AB, Murray MB, Murray CJ: The adverse effect of iron repletion on the course of certain infections. Br Med J [Clin Res] 2 (6145):1113-1115, 1978.
16. Openheimer SJ, Gibson FD, Macfarlane SB, Moody JB, Harrison C, Spencer A, Bunari O: Iron supplementation increases prevalence and effects of malaria: Report on clinical studies in Papua New Guinea. Trans R Soc Trop Med Hyg 80:603-612, 1986.
17. Pattananapanyasat K, Webster HK, Tongtawe P, Kongcharoen P, Hider RC: Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function. Br J Haematol 82:13-19, 1992.
18. Pattanapanyasat K, Webster HK, Udomsangpetch R, Wanachiwanawin W, Yongvanitchit K: Flow cytometric two-color staining technique for simultaneous determination of human crythrocyte membrane antigen and intracellular malarial DNA. Cytometry 13:182-1187, 1992.
19. Pavanand K, Nutakul W, Dechatiwongse T, Yoshihira K, Yongvanitchit K, Scovill JP, Flippen-Anderson JL, Gilardi R, George L, Kanchanapee P, Webster HK: In vitro antimalarial activity of Brucea javanica against multi-drug resistant Plasmodium falciparum. Planta Med 2:108-111, 1986.
20. Peto TEA, Thompson JL: A reappraisal on the effects of Iron and desferrioxamine on the growth of Plasmodium falciparum in vitro: The unimportance of serum iron. Br J Haematol 63:273-280, 1986.
21. Pollack S, Fleming J: Plasmodium falciparum takes up iron from transferrin. Br J Haematol 58:289-293, 1984.
22. Pollack S, Rossan RN, Davidson DE, Escajadillo A: Desferioxamine suppresses Plasmodium falciparum in aotus monkeys. Proc Soc Exp Biol Med 84:162-164, 1987.
23. Raventos-Suarez C, Pollack S, Nagel RL: Plasmodium falciparum: Inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg 31:919-922, 1982.
24. Rieckmann KH, Campbell GH, Sax LJ, Mrema JE: Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet I:22-23, 1978.
25. Rivadeneira EM, Wasserman M, Espinal CT: Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J Protozool 30:367-370, 1983.
26. Singh S, Epemolu RO, Dobbin PS, Tilbrook GS, Ellis BL, Damani LA, Hider RC: Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones. Drug Metab Dispos 20:256-261, 1992.
27. Thaithong S, Beale GH, Chutmongkonkul M: Susceptibility of Plasmodium falciparum to five drugs: An in vitro study of isolates mainly from Thailand. Trans R Soc Trop Med Hyg 77:228-231, 1983.
28. Thaithong S, Beale GH, Chutmongkonkul M: Variability in drug susceptibility amongst clones and isolates of Plasmodium falciparum. Trans R Soc Trop Med Hyg 82:33-36, 1988.
29. Thaithong S, Suebsaeng L, Rooney W, Beale GH: Evidence of increased chloroquine sensitivity in Thai isolates of Plasmodium falciparum. Trans R Soc Trop Med Hyg 82:37-38, 1988.
30. Trager W, Jensen JB: Human malaria parasites in continuous culture. Science 193:674-675, 1976.
31. Van Vianen PH, Thaithong S, Reiders PP, van Engen A, van der Keur M, Tanke HJ, van der Kaay H, Mons B: Automated flow cytometric analysis of drug susceptibility of malaria parasites. Am J Trop Med Hyg 43:602-607, 1990.
32. Webster HK, Boudreau EF, Pavanand K, Yongvanitchit K, Pang LW: Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg 34:228-235, 1985.
33. Whaun JM, Rittershaus C, Ip SHC: Rapid identification and detection of parasitized human red cells by automated flow cytometry. Cytometry 4:117-122, 1983.
34. Whitehead S, Peto TEA: Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro. Blood 76:1250-1255, 1990.
35. World Health Organization: Instructions for the use of the micro test kit for the assessment of the response of Plasmodium falciparum to chloroquine and mefloquine. WHO/MAP/82.1. World Health Organization, Geneva, 1982.
36. Wyler DJ: Malaria-resurgence, resistance and research. N Engl J Med 308:875-878, 1983.